Financial Results: Imaging Solutions

(Billions of yen)

In the Imaging Solutions segment, consolidated revenue in the fiscal year ended March 31, 2019 amounted to ¥386.9 billion (up 1.0% from the previous fiscal year), due to a solid sales increase in all businesses.
Consolidated operating income amounted to ¥51.1 billion (down 8.4% from the previous fiscal year), due to such factors as advertising and promotion costs to expand markets for instant photo systems and value-added printing, and R&D investments for development of new products.

 

 

Consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America.

Financial Results: Healthcare & Material Solutions

(Billions of yen)

In the Healthcare & Material Solutions segment, consolidated revenue in the fiscal year ended March 31, 2019 amounted to ¥1,039.0 billion (up 3.6% from the previous fiscal year) due to strong sales in the medical systems business, bio CDMO business, regenerative medicine business, electronic materials business and others.
Operating income amounted to ¥97.6 billion (up 6.8% from the previous fiscal year), mainly due to increased sales in the medical systems business and bio CDMO business and improved profitability in the pharmaceutical business for the Healthcare, and increased sales in the electronic materials business for the Material.

 

 

Consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America.

Financial Results: Document Solutions

(Billions of yen)

In the Document Solutions segment, consolidated revenue in the fiscal year ended March 31, 2019 amounted to ¥1,005.6 billion (down 4.0% from the previous fiscal year) due to such factors as a reduction in low-profitability parts of the low-end printer business.
Operating income amounted to ¥96.4 billion (up 1,045.3% from the previous fiscal year) due to improved profitability, a positive impact from structural reforms and so on.

 

 

Consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America.

Caution

  • These data are prepared based on the financial results reports.

  • The frequency of updates may change in accordance with changes to the format of the financial results reports.

  • Please see the financial results reports and other materials for detailed information regarding the settlement of accounts.

  • The contents of these data will not immediately reflect corrections to the financial results reports when announced.

  • While we pay due caution to the conversion of data for the posting, please note that there is a possibility that errors may occur in the information due to uncontrollable circumstances, such as the unauthorized alteration of contents by a third party or mechanical defects resulting from equipment malfunction.

  • Service provided by Nomura Investor Relations Co., Ltd.

Powered by